MRC Confidence in Concept (CiC) scheme 2015: Call now open for applications

Written by UMIP on . Posted in News

In the past 2 years, The University of Manchester has funded 30 translational research proposals of up to £100K each under the MRC Confidence in Concept (CiC) scheme. The University has been successful in securing funding from the third round of the MRC CiC scheme providing approximately £1.1M in total funds available. This allocation will provide awards up to £100k (at 80% FEC) and we anticipate projects will have a duration of 6-9 months although we will consider a maximum of 12 months.

The call is now open for applications via submission of a 1-page Expression of Interest.

Deadline: Friday 27th February 2015 (midnight).

For further guidance about the call and the application process please click here.

MRC CiC scheme 2015 launch event4th Feb: Register now

Places are still available for the CiC 2015 launch event on 4th Feb (2-5pm) to share our experience from the previous rounds of the program and provide guidance to potential applicants on how to prepare a competitive CiC proposal.

The launch event will include an overview of the scheme from an MRC representative, an industry perspective on the program, a series of brief presentations about previously-funded projects and details about the process for applications this year. The meeting will end with a drinks reception giving an opportunity for networking and getting advice on your CiC proposal ideas from panel members, Research Deanery, UMIP and business engagement.

Please note that this event is for principal investigators eligible to apply for grant funding.

Read more about this event (including agenda): http://www.mhs.manchester.ac.uk/research/support/deanery/cic3launchevent

Register for this free event via Eventbrite: https://www.eventbrite.co.uk/e/mrc-confidence-in-concept-cic-funding-uom-internal-scheme-launch-event-wed-4th-feb-2015-2-5pm-registration-15203402787

Places are limited and allocated on a first come, first served basis.

Over £1M funding available under the MRC Confidence in Concept (CiC) scheme

Written by UMIP on . Posted in News

Do you have an interesting translational research idea? Over £1M funding available under the MRC Confidence in Concept (CiC) scheme

In the past 2 years, the University of Manchester has funded 30 translational research proposals of up to £100K each under the MRC Confidence in Concept (CiC) scheme. We are holding a launch event for CiC 2015 on 4th Feb to share our experience from the previous rounds of the programme and provide guidance to potential applicants on how to prepare a competitive CiC proposal.

The launch event will include an overview of the scheme from an MRC representative, an industry perspective on the programme, a series of brief presentations about previously-funded projects and details about the process for applications this year. The meeting will end with a drinks reception giving an opportunity for networking and getting advice on your CiC proposal ideas from panel members, Research Deanery, UMIP and business engagement.

Read more about this event (including indicative agenda): http://www.mhs.manchester.ac.uk/research/support/deanery/cic3launchevent

Please register for this free event via Eventbrite: https://www.eventbrite.co.uk/e/mrc-confidence-in-concept-cic-funding-uom-internal-scheme-launch-event-wed-4th-feb-2015-2-5pm-registration-15203402787

Making a Difference Awards Launched

Written by UMIP on . Posted in News

The University’s Social Responsibility team have now launched the ‘Making a Difference’ awards. UMIP has been working closely with the team to help shape a Social Enterprise category.

The ‘Outstanding Social Enterprise of the Year and the ‘Outstanding Aspiring Social Enterprise of the Year’ categories will recognise social enterprises that are innovative and have made significant contributions to creating societal benefit.

The awards are open to all staff, students and recent graduates.

Entrants will be assessed based on either being;

  • an aspiring social enterprise i.e. demonstrating working towards the criteria below
  • or as a social enterprise able to fully demonstrate the criteria below

Social impact: Showing how operations (products, services, business models) have benefitted the community, or how they have committed a significant proportion of profit towards furthering the social purpose.

Business performance and financial viability: Demonstrating effective use of resources and an ability to operate a sustainable business; showing a shift in reliance on grant funding to deriving income through trading is advantageous; demonstrating scalability.

Innovation and productivity: Demonstrating innovative thinking in creation of enterprise and improvements in products/services/processes/delivery.

Leadership and governance:  Demonstrate vision and commitment and providing strategic guidance as well as ensuring corporate governance.

Working environment: Showing how the enterprise is providing a good and safe working environment for employees, specifically disadvantaged ones, including HR practices such as effective communication channels between management and employees.

For more information about the awards and how to apply please follow the link: http://www.socialresponsibility.manchester.ac.uk/get-involved/awards/

The closing date for entries is the 2nd March and we would like to encourage you to get involved and raise the profile of your enterprise within the University. Don’t forget you can apply yourself or even nominate someone else. All entries will be assessed by a judging panel. Shortlisted initiatives will be profiled on the University website and at a special awards ceremony in Whitworth Hall, hosted by the President and Vice-Chancellor on the evening of 7 May 2015.

For further details about the social enterprise award categories, please contact Ellie Buckley ellie.buckley@umip.com, or Laura Etchells laura.etchells@umip.com.

Ximbio, in partnership with UMIP, to exhibit at The University of Manchester

Written by UMIP on . Posted in News

Ximbio aims to change the way research reagents are searched, sourced and shared

Ximbio (www.ximb.io), an online reagents portal for the life science community which originates from Cancer Research Technology (CRT), the development and commercialisation arm of Cancer Research UK, and UMIP, The University of Manchester’s agent for IP commercialisation, announce Ximbio will be exhibiting at The University of Manchester on 20th and 21st January 2015.

Researchers interested in learning how Ximbio can help increase the global visibility of their new and already developed research tools, and help manage requests for those reagents, are invited to contact Dr Melanie Hardman from Ximbio (E: melanie@ximb.io, T: 020 3469 6449 or 07733 220175) to arrange a one-to-one discussion. Alternatively Melanie will be available at the Ximbio exhibition stand on Tuesday 20th January at the Michael Smith Building, and on Wednesday 21st January at the MIB John Garside Building.

Ximbio is an online portal for the life science community to exchange knowledge and trade reagents. Researchers can virtually deposit reagents, to raise their profile and share research globally. The Ximbio community benefits from Ximbio’s existing relationships with more than 100 life science reagents companies. Deposited reagents can be ‘tagged’ with details of the laboratory where they were developed, to make it easier for future users to cite the originating source in publications. Researchers can also use Ximbio to help make an informed decision about where to source a product from, and share experiences of using specific reagents with others.

Melanie Hardman, Head of Ximbio, commented: “We are excited to visit The University of Manchester, in collaboration with UMIP. We created Ximbio to be a place where the reagent community can be unified, maximising the visibility and impact of all research reagents and making them more widely and easily available, to help accelerate life science research. We look forward to working with Manchester based researchers.”

Dr. Ed Maughfling, Express Licensing Manager, UMIP, said: “Research reagents represent one of four key product areas (along with software, clinical questionnaires and images) of UMIP’s Express IP portfolio (http://umip.com/what-is-express-ip/). As part of UMIP’s strategy of developing either online sales capability (www.click2go.umip.com) or working with a preferred licensing partner, UMIP and Ximbio hope to work together to identify, disseminate and commercialise research reagents developed at The University of Manchester.”

Flyer download Ximbio visit

Contacts:

Media contacts

Zyme Communications Ltd.

Lorna Cuddon / Katie Odgaard

e-mail: lorna.cuddon@zymecommunications.com/katie.odgaard@zymecommunications.com

Tel: +44 (0)7811 996 942 / +44 (0)7787 502 947

About Ximbio (www.ximb.io)

Ximbio will change the way life science reagents are searched, sourced and shared.

Through Ximbio researchers and technology transfer offices can virtually deposit their reagents free of charge to an online portal. Each reagent record can be linked to the originating inventor, enabling scientists and institutions to be credited for their work.

  • Life science reagents companies can use Ximbio to easily source new products to augment their portfolios via a straightforward commercialisation process.
  • Ximbio offers scientists looking for a specific reagent with a fully searchable database, extensive datasheets, peer reviews and supplier options.

Ximbio is owned by Cancer Research Technology (CRT). A share of product-based revenues is returned to the depositing institution.

Ximbio will focus on all areas of biology, and will broaden the range of tools available to scientists globally, to support and advance life science research.

About Cancer Research Technology

Cancer Research Technology Limited (CRT) is a specialist commercialisation and development company, which aims to develop new discoveries in cancer research for the benefit of cancer patients. CRT works closely with leading international cancer scientists and their institutes to protect intellectual property arising from their research and to establish links with commercial partners. CRT facilitates the discovery, development and marketing of new cancer therapeutics, vaccines, diagnostics and enabling technologies. CRT is wholly owned by Cancer Research UK, the world’s leading cancer charity dedicated to saving lives through research.

C4X Discovery renews collaboration with Evotec AG

Written by UMIP on . Posted in News

C4X Discovery (C4XD), a leader in rational drug discovery and design, announced today that it has extended its research collaboration agreement with Evotec, under which C4XD’s proprietary NMR-based technology and conformational design expertise is applied across a number of Evotec’s pre-clinical therapeutic projects to enhance lead discovery and hit identification.

C4XD has the only technology in the world that can generate accurate, experimentally-derived dynamic solution 3D structures of drug molecules in just a matter of days, helping to accelerate product development. It can be used in conjunction with existing technologies for structure-based drug design and can make a particularly high impact when protein crystallography is not routinely available, as is the case for GPCRs and ion channels.

The technology can also be applied to help identify and generate novel crystal polymorph forms, with exciting potential applications in the life cycle management of existing branded pharmaceuticals.

Piers Morgan, CEO of C4X, said “We are delighted to renew and extend our partnership with Evotec, a global leader in high-quality drug discovery solutions. This collaboration has generated valuable data underpinning the advantages and benefits of C4XD’s technology.”

Dr Mario Polywka, Chief Operating Officer of Evotec, commented: “We are pleased to continue working with C4XD and are excited by the progress so far with this alliance. C4XD has a highly innovative platform technology which complements our strong research base to accelerate product development.”

 

For further information please contact:

C4X Discovery Ltd

Piers Morgan, CEO                                                                        07912 293832

Ross Andrews / Dan Bate, Zeus Capital                                        016 1831 1512

Dominic Wilson, Zeus Capital                                                         020 7533 7727

Matthew Cole / Ben Atwell / Matthew Moss, FTI Consulting         020 3727 1000

comms@c4xdiscovery.com

UMIP - REPUTATION AND VALUE THROUGH INTELLECTUAL PROPERTY®

Privacy Policy / Terms and Conditions / © Copyright 2014 The University of Manchester Intellectual Property / Created by HTP Digital

The University of Manchester Intellectual Property ("UMIP") acts solely as agent for the University in relation to any matter relating to intellectual property ("IP") and know how created at the University. This is whether such IP is created by employees, students or others. UMIP does not represent anyone else in such matters. If anyone else requires advice in relation to such IP then they must take their own independent legal advice.